PMID: 3769196Oct 1, 1986Paper

Abnormalities of circulating immunoreactive pancreatic anionic trypsinogen in cystic fibrosis: an assay artifact due to cross-reacting serum antibodies

Clinical Biochemistry
D J MooreP Durie

Abstract

In patients with CF, serum pancreatic cationic trypsinogen has proven to be useful for newborn diagnostic screening and also as a test of pancreatic function in the older patient. However, an assay for serum anionic trypsinogen is of no value as a test of pancreatic function in CF due to an apparent artifactual elevation of this enzyme in some patients. In this study, we evaluated the extent of the abnormality in the anionic trypsinogen assay and also elucidated the nature of the interfering material. CF patients were grouped according to the presence (pancreatic insufficiency) or absence (pancreatic sufficiency) of steatorrhea. In CF infants, both serum cationic and anionic trypsinogen levels were greatly elevated. Serum cationic trypsinogen declined with age in patients with pancreatic insufficiency, reaching low or undetectable levels after 6 years. In contrast, serum anionic trypsinogen levels remained normal or elevated in 33% of those over 6 years of age. There was no age-related change in either cationic or anionic trypsinogen among the CF patients with pancreatic sufficiency, and the majority had normal or elevated levels. Serum samples from selected CF patients were separated into IgG and non-IgG fractions using Staph....Continue Reading

References

Mar 3, 1979·Lancet·J R CrossleyP A Smith
Aug 31, 1978·Nature·G RomeoL Cavalli-Sforza
Nov 1, 1978·Biochimica Et Biophysica Acta·C LargmanJ H Johnson
Oct 1, 1970·The American Journal of Clinical Nutrition·S J FomonL J Filer
Sep 1, 1980·Pediatric Research·M Denaro, G Romeo
Jan 1, 1981·Methods in Enzymology·C LargmanM C Geokas
Jan 1, 1982·Journal of Pediatric Gastroenterology and Nutrition·P R DurieC Largman

❮ Previous
Next ❯

Citations

Dec 11, 2008·Journal of Gastroenterology and Hepatology·Antonio M Morselli-Labate, Raffaele Pezzilli

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.